Acino: Allecra & Acino ink licensing and supply agreement for Allecra's novel antibiotic Exblifep in GCC countries and South Africa
Allecra Therapeutics (Allecra) and Acino announced the signing of an exclusive licensing agreement under which Acino gains the rights to commercialise Allecra's antibiotic drug Exblifep (cefepime/
Read full article »
Acino is a Switzerland-based pharmaceutical company that provides services such as CRO and out-licensing for the healthcare industry.
Read more